Corcept Therapeutics Appoints Daniel M. Bradbury to Board of Directors

Corcept Therapeutics Appoints Daniel M. Bradbury to Board of Directors

[at noodls] – MENLO PARK, Calif. – October 15, 2012 Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of … more

View todays social media effects on CORT

View the latest stocks trending across Twitter. Click to view dashboard

Share this post